is semaglutide a glp-1 Side Effects and Semaglutide: Why Smart Biomarker Monitoring Matters Semaglutide | GLP-1 RA |

All the other companies (Viking Therapeutics, Structure Therapeutics, Altimmune, etc.) have either just completed Phase 2 or are still in Phase 2, which means any results will take years to materialize

11.7 Practical Takeaway Framework During GLP-1 therapy: Prioritise protein intake Increase micronutrient density per calorie Monitor symptoms Test selectively when risk factors are present Avoid automatic or excessive supplementation Reassess after significant weight milestones Weight loss should be metabolically effective and nutritionally sufficient

These omics-based biomarkers are promising for future clinical stratification, but require validation and standardization before widespread adoption [130,137]

It also has better outcomes than gastroparesis [31]

Idiopathic causes: Sometimes, the cause of gastroparesis is not known